Table 4.
Comparative analysis of variables measured for the CG at the initial and final assessments.
| Parameter | Measur. | Med | IQR | Min | Max | Sk. | Z | p | r |
|---|---|---|---|---|---|---|---|---|---|
| EPIC-26 (overall urinary difficulties) | B | 2 | 2.5 | 1 | 5 | 0.64 | |||
| A | 5 | 1 | 3 | 5 | −0.84 | ||||
| A-B | 3 | 2 | −2 | 4 | −0.85 | −3.01 | 0.0096 | 0.78 | |
| EPIC-26 (incontinence subscale) | B | 9 | 0 | 7 | 10 | −1.24 | |||
| A | 9 | 1 | 7 | 10 | −0.37 | ||||
| A-B | 0 | 1 | −2 | 2 | 0 | 0 | 1 | 0 | |
| EPIC-26 (irritation/obstruction subscale) | B | 4 | 4 | 0 | 9 | 0.38 | |||
| A | 4 | 5.5 | 0 | 9 | −0.05 | ||||
| A-B | 1 | 3 | −7 | 8 | 0.09 | −1.27 | 0.7492 | 0.33 | |
| EPIC-26 (vitality or hormonal symptom) | B | 2 | 3.5 | 0 | 8 | 0.71 | |||
| A | 5 | 5 | 0 | 15 | 0.96 | ||||
| A-B | 1 | 7.5 | −4 | 13 | 0.59 | −1.34 | 0.7492 | 0.35 | |
| EPIC-26 (bowel domain) | B | 4 | 5.5 | 1 | 8 | 0.17 | |||
| A | 6 | 4.5 | 1 | 11 | −0.08 | ||||
| A-B | 1 | 3 | −2 | 6 | 0.44 | −2.07 | 0.2884 | 0.53 | |
| EPIC-26 (sexual symptom) | B | 19 | 2 | 11 | 24 | −0.54 | |||
| A | 10 | 1 | 6 | 15 | 0.56 | ||||
| A-B | −9 | 2.5 | −14 | 4 | 1.65 | 3.36 | 0.0009 | 0.87 | |
| IPSS | B | 11 | 8 | 3 | 28 | 0.97 | |||
| A | 18 | 14 | 7 | 28 | −0.05 | ||||
| A-B | 2 | 13.5 | −6 | 23 | 0.76 | −1.76 | 0.402 | 0.46 | |
| BDI-II | B | 5 | 4 | 0 | 17 | 1.1 | |||
| A | 5 | 6.5 | 0 | 15 | 0.53 | ||||
| A-B | 1 | 4.5 | −13 | 8 | −0.86 | −0.6 | 1 | 0.15 | |
| myostatin concentration | B | 91.91 | 24.33 | 65.28 | 169.76 | 0.94 | |||
| A | 91.47 | 33.2 | 45.98 | 162.71 | 0.34 | ||||
| A-B | −5.21 | 7.71 | −19.3 | 15.6 | 0.19 | 1.93 | 0.339 | 0.5 |
Min: minimum; Max: maximum; Med: median; IQR: interquartile range; Sk: skewness, Z: Z statistic; r: r statistic; p: significance level.